Both in Biotechnology
CRISPR Therapeutics AG vs Kodiak Sciences
Over the past year CRSP returned −12.2% and KOD returned +476.3%; their daily moves had a correlation of 0.18.
CRSP −12.2% KOD +476.3%Growth of $1, one year, split-adjusted
| Metric | CRSP | KOD |
|---|---|---|
| Price | $56.00 | $91.12 |
| Market cap | $5.41B | $5.73B |
| Today | +3.53% | +1.33% |
| 1 month | −3.0% | +141.6% |
| 6 months | +26.3% | +170.7% |
| Year to date | +6.8% | +225.9% |
| 1 year | −9.2% | +476.7% |
| Revenue growth (YoY) | +1041.4% | — |
| Gross margin | 100.0% | — |
| Net margin | −895.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 404.3× | — |
| Net cash | $1.78B | $125.9M |
| Dividend yield | — | — |
| Volatility (60d) | 52.4% | 214.5% |
| Short % of float | 23.1% | 34.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).